Allegiance Financial Group Advisory Services LLC Purchases Shares of 631 Medpace Holdings, Inc. (NASDAQ:MEDP)

Allegiance Financial Group Advisory Services LLC purchased a new stake in Medpace Holdings, Inc. (NASDAQ:MEDP) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 631 shares of the company’s stock, valued at approximately $210,000.

Other large investors also recently made changes to their positions in the company. State Street Corp increased its stake in shares of Medpace by 7.2% during the third quarter. State Street Corp now owns 752,957 shares of the company’s stock valued at $251,337,000 after acquiring an additional 50,312 shares during the period. Geode Capital Management LLC increased its stake in shares of Medpace by 7.6% during the third quarter. Geode Capital Management LLC now owns 628,054 shares of the company’s stock valued at $209,885,000 after acquiring an additional 44,371 shares during the period. Wellington Management Group LLP increased its stake in shares of Medpace by 36.0% during the third quarter. Wellington Management Group LLP now owns 415,255 shares of the company’s stock valued at $138,612,000 after acquiring an additional 109,886 shares during the period. American Capital Management Inc. increased its stake in shares of Medpace by 2.6% during the third quarter. American Capital Management Inc. now owns 380,646 shares of the company’s stock valued at $127,060,000 after acquiring an additional 9,592 shares during the period. Finally, FMR LLC increased its stake in shares of Medpace by 11.8% during the third quarter. FMR LLC now owns 231,019 shares of the company’s stock valued at $77,114,000 after acquiring an additional 24,362 shares during the period. Institutional investors and hedge funds own 77.98% of the company’s stock.

Medpace Stock Performance

Medpace stock opened at $339.48 on Thursday. The company has a 50 day moving average price of $343.04 and a 200 day moving average price of $346.19. Medpace Holdings, Inc. has a 52 week low of $302.01 and a 52 week high of $459.77. The firm has a market capitalization of $10.34 billion, a price-to-earnings ratio of 26.88, a P/E/G ratio of 3.81 and a beta of 1.36.

Medpace (NASDAQ:MEDP) last posted its quarterly earnings data on Monday, February 10th. The company reported $3.67 EPS for the quarter, topping analysts’ consensus estimates of $2.96 by $0.71. Medpace had a net margin of 19.17% and a return on equity of 51.48%. Equities analysts forecast that Medpace Holdings, Inc. will post 12.29 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Robert W. Baird raised their target price on shares of Medpace from $354.00 to $362.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $381.44.

Medpace Company Profile

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.